dihydroxyphenylalanine has been researched along with Arterial Occlusive Diseases in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vaccaro, E | 1 |
| Solitro, A | 1 |
| Barba, C | 1 |
1 other study available for dihydroxyphenylalanine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Levodopa in the treatment of arterial insufficiency of the lower limbs. Clinical and rheographic trial.
Topics: Administration, Oral; Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Dihydro | 1973 |